Chris Orvig

Chris Orvig's AcademicInfluence.com Rankings

Chris Orvig

Chemistry

#3515

World Rank

#4537

Historical Rank

Inorganic Chemistry

#169

World Rank

#181

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Chris Orvig's Degrees

PhD Inorganic Chemistry University of British Columbia
Bachelors Chemistry University of British Columbia

Why Is Chris Orvig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Chris Orvig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Metallodrugs in medicinal inorganic chemistry. (2014) (827)
Vanadium compounds as insulin mimics. (1999) (635)
Matching chelators to radiometals for radiopharmaceuticals. (2014) (559)
Biosorbents for hexavalent chromium elimination from industrial and municipal effluents (2010) (478)
Vanadium in diabetes: 100 years from Phase 0 to Phase I. (2006) (436)
Vanadium treatment of type 2 diabetes: a view to the future. (2009) (427)
Medicinal inorganic chemistry: introduction. (1999) (407)
Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. (1992) (354)
Boon and Bane of Metal Ions in Medicine (2003) (323)
Design of targeting ligands in medicinal inorganic chemistry. (2006) (262)
Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. (2009) (252)
Metal complexes in medicinal chemistry: new vistas and challenges in drug design. (2006) (246)
Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent (1995) (210)
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy. (2018) (196)
Potentiometric, Calorimetric, and Solution NMR Studies of a Tridentate Ligand Which has a Marked Preference for Formation of Bis(ligand) versus Mono(ligand) Lanthanide Complexes and Which Exhibits High Selectivity for Heavier Lanthanides (1995) (192)
Tumour targeting with radiometals for diagnosis and therapy. (2013) (185)
Synthesis and characterization of lanthanide [Ln(L)]2 complexes of N4O3 amine phenol ligands with phenolate oxygen bridges: evidence for very weak magnetic exchange between lanthanide ions (1992) (168)
Speciation of aluminum in biological systems. (1996) (157)
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential (2002) (148)
Design of vanadium compounds as insulin enhancing agents (2000) (139)
Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin (2014) (139)
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. (2005) (138)
The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases (2012) (130)
Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. (2007) (129)
Neutral water-soluble aluminum complex of neurological interest (1986) (128)
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. (2005) (127)
Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration. (2010) (121)
Metal complexes of maltol and close analogues in medicinal inorganic chemistry. (2006) (120)
Vanadium Complexes as Insulin Mimetic Agents: Coordination Chemistry and in Vivo Studies of Oxovanadium(IV) and Dioxovanadate(V) Complexes Formed from Naturally Occurring Chelating Oxazolinate, Thiazolinate, or Picolinate Units† (1999) (108)
Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. (2007) (104)
Neutral water-soluble post-transition-metal chelate complexes of medical interest: aluminum and gallium tris(3-hydroxy-4-pyronates) (1987) (100)
Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. (2004) (99)
Structural, Spectroscopic, Thermodynamic and Kinetic Properties of Copper(II) Complexes with Tripodal Tetraamines. (1998) (99)
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. (2004) (98)
Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats. (1998) (96)
Vanadyl-biguanide complexes as potential synergistic insulin mimics. (1999) (94)
Insulin-enhancing vanadium(III) complexes. (2001) (94)
Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. (1995) (92)
A Perspective - can copper complexes be developed as a novel class of therapeutics? (2017) (91)
Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). (1993) (91)
Lanthanide containing compounds for therapeutic care in bone resorption disorders. (2007) (87)
Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. (1997) (86)
Werner coordination chemistry and neurodegeneration. (2013) (86)
Ion exchange in hydroxyapatite with lanthanides. (2015) (85)
Aluminum and gallium compounds of 3-hydroxy-4-pyridinones: synthesis, characterization, and crystallography of biologically active complexes with unusual hydrogen bonding (1988) (80)
Preparation of oxobis(dithiolato) complexes of technetium(V) and rhenium(V) (1980) (80)
Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). (1993) (78)
H4octapa: an acyclic chelator for 111In radiopharmaceuticals. (2012) (76)
A new class of oxotechnetium(5+) chelate complexes containing a TcON2S2 core (1981) (76)
Characterization of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Solution by EPR Spectroscopy. (1996) (75)
Coordination chemistry of 2-(2'-hydroxyphenyl)-2-oxazolines with aluminum, gallium, and indium: first tris(ligand)metal(III) complexes of this naturally occurring binding group (1992) (73)
Carbohydrate conjugates for molecular imaging and radiotherapy: 99mTc(I) and 186Re(I) tricarbonyl complexes of N-(2'-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. (2004) (72)
Complexes of Trivalent Metal Ions with Potentially Heptadentate N4O3 Schiff Base and Amine Phenol Ligands of Varying Rigidity (1995) (69)
RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. (2012) (65)
99m-Technetium carbohydrate conjugates as potential agents in molecular imaging. (2008) (64)
Carbohydrate-appended 2,2'-dipicolylamine metal complexes as potential imaging agents. (2005) (63)
Heptadentate ligands for the lanthanides. The first structurally characterized example of a lanthanide heptadentate ligand complex: [tris(3-aza-4-methyl-6-oxohept-4-en-1-yl)amine]ytterbium(III) (1991) (63)
Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones (1991) (63)
Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry. (2009) (63)
New class of oxotechnetium (5+) chelate complexes containing a TcON/sub 2/S/sub 2/ core (1981) (62)
Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms. (2013) (62)
Vanadium compounds in the treatment of diabetes. (2004) (61)
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. (2013) (61)
Increased potency of vanadium using organic ligands (1995) (60)
Geometric Factors in the Structural and Thermodynamic Properties of Copper(II) Complexes with Tripodal Tetraamines (1996) (60)
Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. (2009) (59)
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy (2011) (58)
Physical and structural studies of N-substituted-3-hydroxy-2-methyl-4(1H)-pyridinones (1988) (58)
A glucosamine-dipicolylamine conjugate of 99mTc(I) and 186Re(I) for use in imaging and therapy. (2005) (58)
Novel carbohydrate-appended metal complexes for potential use in molecular imaging. (2004) (57)
Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies. (2005) (55)
Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid. (2005) (55)
Bis(ligand) Rhenium(V) and Technetium(V) Complexes of Two Naturally Occurring Binding Moieties (Oxazoline and Thiazoline). (1996) (55)
Homotrinuclear lanthanide(III) arrays: assembly of and conversion from mononuclear and dinuclear units. (2000) (54)
Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminium and gallium (1990) (52)
Two-dimensional (2D) pulsed electron paramagnetic resonance study of VO(2+)-triphosphate interactions: evidence for tridentate triphosphate coordination, and relevance to bone uptake and insulin enhancement by vanadium pharmaceuticals. (2002) (52)
Divalent later transition metal complexes of the traditional chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies. (2009) (52)
Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core. (2008) (51)
Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V). (1982) (51)
Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates. (2006) (51)
Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol. (1996) (50)
Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme. (2015) (50)
Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats. (1996) (50)
Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid. (2004) (50)
Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores. (2006) (49)
Reduction of [VO2(ma)2]- and [VO2(ema)2]- by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. (2002) (49)
Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re). (2006) (49)
Rhenium(V) and technetium(V) complexes of bis(o-hydroxyphenyl)phenylphosphine (PO{sub 2}{sup 2-}) and (o-hydroxyphenyl)diphenylphosphine (PO{sup -}) ligands (1995) (48)
The complexation of aluminum with N-substituted 3-hydroxy-4-pyridinones (1989) (48)
Evaluation of the H2)dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu. (2012) (48)
Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers. (2005) (47)
Bulky ortho 3-methoxy groups on N4O3 amine phenol ligands producing six-coordinate bis(ligand)lanthanide complex cations [Ln(H3L)2]3+ (Ln = Pr, Gd; H3L = tris(((2-hydroxy-3-methoxybenzyl)amino)ethyl)amine) (1993) (47)
Solution chemistry of gallium and indium 3-hydroxy-4-pyridinone complexes in vitro and in vivo (1990) (46)
Octadentate Picolinic Acid-Based Bispidine Ligand for Radiometal Ions. (2017) (45)
Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes. (2001) (45)
An Iron-Based Molecular Redox Switch as a Model for Iron Release from Enterobactin via the Salicylate Binding Mode. (1999) (43)
Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron (2002) (43)
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. (2010) (43)
Coordination chemistry of 2-(2'-hydroxyphenyl)-2-benzoxazole with gallium(III) and aluminum(III): two uncommon Group 13 metal environments stabilized by a biologically relevant binding group (1993) (42)
Vanadyl-thiazolidinedione combination agents for diabetes therapy. (2003) (41)
Editorial: lanthanide compounds for therapeutic and diagnostic applications. (2006) (41)
H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals. (2015) (41)
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. (2014) (41)
Group 13 and lanthanide complexes with mixed O,S anionic ligands derived from maltol. (2005) (40)
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. (2012) (40)
Dlf complexes with uniform coordination geometry: structural and magnetic properties of an LnNi2 core supported by a heptadentate amine phenol ligand. (2003) (39)
Evidence for energy-dependent transport of aluminum out of brain extracellular fluid. (1995) (39)
Polydentate ligand chemistry of Group 13 metals: effects of the size and donor selectivity of metal ions on the structures and properties of aluminum, gallium, and indium complexes with potentially heptadentate (N4O3) amine phenol ligands (1992) (39)
Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. (2009) (38)
Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats (2002) (38)
Neutral water-soluble indium complexes of 3-hydroxy-4-pyrones and 3-hydroxy-4-pyridinones (1988) (38)
Vanadium compounds as insulin mimics. (1999) (37)
[(μ-OCH3)VO(ma)]2, a Strongly Antiferromagnetic Oxovanadium(IV) Dimer (1998) (37)
Highly flexible chelating ligands for group 13 metals : design and synthesis of hexadentate (N3O3) tripodal amine phenol ligand complexes of aluminum, gallium, and indium (1993) (37)
Coaggregation of paramagnetic d- and f-block metal ions with a podand-framework amine phenol ligand. (2000) (37)
Sugar-pendant diamines. (2001) (36)
Lanthanide complexes of potentially heptadentate ligands including the structure of [tris(3-aza-4-methylhept-4-ene-6-on-1-yl)amine]tris(nitrato)gadolinium(III) (1988) (36)
Aluminum and gallium complexes of 1-ethyl-3-hydroxy-2-methyl-4-pyridinone: a new exoclathrate matrix (1989) (36)
Hexadentate N4O2 Amine Phenol Complexes of Gallium and Indium (1995) (36)
Tripodal Aminophenolate Ligand Complexes of Aluminum(III), Gallium(III), and Indium(III) in Water (1997) (35)
Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III). (2005) (34)
Multi-Target Metal-Based Anticancer Agents. (2017) (34)
Structural characterization of the octachloroditechnetate(III) ion in its tetrabutylammonium salt (1981) (33)
In vitro studies of lanthanide complexes for the treatment of osteoporosis. (2013) (33)
New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake. (2011) (33)
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. (2008) (32)
Gallium and Indium Complexes of Hexadentate Ligands Containing Pendant Pyridyl and Phenolate Groups (1995) (32)
Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. (2009) (32)
Effects of sequential replacement of -NH2 by -OH in the tripodal tetraamine tren on its acidity and metal ion coordinating properties. (2001) (31)
What a Difference a Carbon Makes: H4octapa vs H4C3octapa, Ligands for In-111 and Lu-177 Radiochemistry (2014) (30)
Tightening the Hydrophobic Belt: Effects of Backbone and Donor Group Variation on Podand Ligand Complexes of the Lanthanides (1998) (30)
IN VIVO ELECTRON SPIN-ECHO ENVELOPE MODULATION (ESEEM) SPECTROSCOPY : FIRST OBSERVATION OF VANADYL COORDINATION TO PHOSPHATE IN BONE (1999) (29)
General method for the synthesis of trishydroxamic acids (1992) (29)
Long-chain rhenium and technetium glucosamine conjugates. (2009) (28)
Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry. (1997) (28)
Selectivity of Potentially Hexadentate Amine Phenols for Ga3+ and In3+ in Aqueous Solution†,‡ (1996) (28)
Rhenium(V) and technetium(V) complexes of bidentate (O,O) monobasic 3-oxy-4-pyronato and -4-pyridinonato ligands. X-ray structures of cis-bromobis(3-methyl-2-oxy-4-pyronato)oxorhenium(V), tetra-n-butylammonium tribromo(3-methyl-2-oxy-4-pyronato)oxorhenate(V), and tetra-n-butylammonium trichloro(3-me (1993) (28)
Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease (2010) (28)
1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine Conjugates as Potential Antimalarials (2012) (27)
Functionally Versatile and Highly Stable Chelator for 111In and 177Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting. (2019) (27)
p-NO2-Bn-H4neunpa and H4neunpa-Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and 111In Immuno-Single Photon Emission Computed Tomography Imaging. (2017) (26)
Modular Synthesis of 1,2- and 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine and Mefloquine Conjugates as Potential Antimalarial Agents (2012) (26)
Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin. (2015) (26)
1,2-disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents. (2012) (26)
Dipicolinate Complexes of Gallium(III) and Lanthanum(III). (2016) (25)
Exoclathrate Al(C7H8NO2)3.cntdot.12H2O. A facial geometry imposed by extensive hydrogen bonding with the ice I structure (1987) (25)
Radiopharmaceuticals for diagnosis in nuclear medicine: a short review (2019) (25)
Synthesis and Coordination Chemistry of Hexadentate Picolinic Acid Based Bispidine Ligands. (2016) (25)
Cationic Lanthanide Complexes of N,N'-Bis(2-pyridylmethyl)ethylenediamine-N,N'-diacetic Acid (H(2)bped). (1997) (24)
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225Ac (2019) (24)
Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease. (2013) (24)
Lanthanide chemistry with (bis[[bis(carboxymethyl)amino]methyl]phosphinate: what does an extra phosphinate group do to EDTA? (2001) (24)
Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). (1997) (24)
Synthesis and characterization of a pentadentate Schiff base N3O2 ligand and its neutral technetium(V) complex. X-ray structure of {N,N'-3-azapentane-1,5-diylbis(3-(1-iminoethyl)-6-methyl-2H-pyran-2,4(3H)-dionato)(3-)-O,O',N,N',N''}oxotechnetium(V) (1991) (23)
225Ac-H4py4pa for Targeted-Alpha-Therapy. (2020) (23)
A survey of reducing agents for the synthesis of tetraphenylarsonium oxotechnetiumbis(ethanedithiolate) from [99Tc] pertechnetate in aqueous solution. (1980) (23)
The Aqueous Coordination Chemistry of Aluminum (1993) (23)
Complexation of iron with the orally active decorporation drug L1 (3-hydroxy-1,2-dimethyl-4-pyridinone). (1992) (22)
Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc). (2009) (22)
H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry. (2018) (22)
Complexation of the potentially heptadentate ligand H3dha3tren with lanthanides: architecture of a [Nd(NO3)3(H3dha3tren)]n polymer with profuse modes of nitrate coordination (1995) (21)
Molecular architectures for trimetallic d/f/d complexes: magnetic studies of a LnCu2 core. (2008) (21)
Cationic technetium and rhenium complexes with pendant carbohydrates. (2010) (21)
Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga. (2015) (21)
Physical and structural studies of N-carboxymethyl- and N-(p-methoxyphenyl)-3-hydroxy-2-methyl-4-pyridinone (1992) (21)
In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders† †Electronic supplementary information (ESI) available: Speciation diagrams for metal–ligand complexes (Fig. S1 and S3), ITC analysis of H5XT-hydroxyapatite t (2015) (21)
In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors. (2016) (20)
Metal chelation with natural products: isomaltol complexes of aluminum, gallium, and indium (1989) (20)
Complexation of gallium(III) by 2-hydroxynicotinic acid and 3-hydroxypicolinic acid in aqueous solution (1998) (20)
Hexadentate N3O3 amine phenol ligands for Group 13 metal ions: evidence for intrastrand and interstrand hydrogen-bonds in polydentate tripodal amine phenols (1993) (20)
Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models. (2015) (20)
H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals. (2018) (20)
1-n-Propyl- and 1-n-butyl-3-hydroxy-2-methyl-4-pyridinone complexes of group 13 (IIIA) metal ions (1991) (19)
Rhenium and technetium complexes from pentadentate (N3O2) and tetradentate (N2O2) Schiff base ligands (1995) (19)
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y. (2016) (19)
Improved separation of the curcuminoids, syntheses of their rare earth complexes, and studies of potential antiosteoporotic activity. (2014) (19)
Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes. (2017) (19)
One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co. (2011) (18)
Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent. (2020) (18)
Gallium(iii) and iron(iii) complexes of quinolone antimicrobials. (2016) (17)
Synthesis and solution studies of the complexes of pyrone analogue ligands with vanadium(IV) and vanadium(V) (2002) (17)
Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. (1997) (17)
The preparation, characterization, and crystal and molecular structure of oxobis(ethan-1,2-dithiolato-S,µS′)technetium(V)oxo(ethan- 1,2-dithiolato-S,S′)technetium(V) [(TcO)2(SCH2CH2S)3]. A Tc(V) compound containing metal—sulfur—metal bridges (1985) (17)
55Cobalt complexes with pendant carbohydrates as potential PET imaging agents. (2007) (17)
Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals. (2014) (17)
3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. (2014) (17)
In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands. (2019) (17)
Structure of yttrium octachloroditechnetate nonahydrate (1982) (17)
Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc). (2008) (16)
Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2. (2002) (16)
Mononuclear to Tetranuclear Structural Transformation in Vanadyl Complexes of 3-Hydroxypyridine-2-carboxylic Acid (H2hpic) (2002) (16)
Synthesis and in vitro anticancer activity of ferrocenyl-aminoquinoline-carboxamide conjugates (2012) (16)
Coordination chemistry of P, O-bidentate phosphinophenolates with Ga3+ and In3+. (2005) (16)
Field desorption mass spectrometry of complex anions containing rhenium and technetium (1979) (15)
Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models. (2019) (15)
Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands. (2016) (15)
Chemical and Pharmacological Studies of a New Class of Antidiabetic Vanadium Complexes (1998) (15)
H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions. (2017) (15)
Seven-coordinate [ReVON4X2]+ complexes (X = O and Cl). (2000) (15)
Harnessing the bone-seeking ability of Ca(II)-like metal ions in the treatment of metastatic cancer and resorption disorders. (2016) (14)
3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability. (2015) (14)
Cationic iron(III) complex with a hexadentate N2,N'2',O2-aminopyridylphenolate ligand (1999) (14)
Oxobis(2,4-pentanedionato)vanadium(IV), a Redetermination (1995) (14)
[nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. (2020) (13)
Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy. (1994) (12)
Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates. (2019) (12)
A Neutral Water-Soluble Aluminum Complex of Neurological Interest. (1986) (12)
Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry. (2019) (12)
VO2+–hydroxyapatite complexes as models for vanadyl coordination to phosphate in bone (2013) (11)
Chemistry of re with N,N'-bis(2-pyridylmethyl)ethylenediamine (H2pmen): hydrolysis, dehydrogenation, and ternary complexes. (2001) (11)
Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions. (2020) (11)
Highly Symmetric Group 13 Metal−Phosphinato Complexes: Multinuclear NMR (27Al,31P,71Ga) Determination of Stability Constants at Low pH (1996) (11)
Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review (2021) (11)
Design and synthesis of multidentate 2-(2′-hydroxyphenyl)-2-thiazolines for biomedical application (1992) (11)
99m‐Technetium Carbohydrate Conjugates as Potential Agents in Molecular Imaging (2009) (11)
Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes. (1992) (10)
Thorium chelators for Targeted Alpha Therapy: Rapid chelation of thorium-226. (2020) (10)
Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones. (2014) (10)
Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats. (2003) (10)
Evaluation of H2CHXdedpa, H2dedpa- and H2CHXdedpa-N,N'-propyl-2-NI ligands for (64)Cu(ii) radiopharmaceuticals. (2016) (10)
In vivo coordination chemistry and biolocalization of Bis(ligand)orovanadium(IV)complexes for diabetes treatment (2005) (10)
H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3. (2020) (10)
The Chemistry of Inorganic Nuclides (86Y, 68Ga, 64Cu, 89Zr, 124I) (2014) (9)
Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: H4neunpa-NH2 vs H4noneunpa. (2021) (9)
Potential 99mTc radiopharmaceuticals for renal imaging: tris(N-substituted-3-hydroxy-2-methyl-4-pyridinonato)technetium(IV) cations. (1993) (9)
Design, synthesis, and imaging of small amphiphilic rhenium and (99m)technetium tricarbonyl complexes. (2009) (9)
Tripodal trisamides based on nicotinic and picolinic acid derivatives (1998) (9)
Theoretical studies of the tautomers of pyridinethiones. (2008) (9)
Vanadium-Containing Insulin Biomimetic Drugs (1999) (9)
Biolocalization and in vivo coordination chemistry of vanadium pharmaceuticals (2003) (8)
A simple method to perform a liquid diffusion crystallization (1985) (8)
Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH Responsive Hepatocellular Carcinoma-Targeted Drug Delivery. (2020) (8)
Characterization of Tris(N-substituted-2-methyl-3-hydroxy-4-pyridinonato)technetium(IV) Cations (1994) (8)
Acid–base and metal ion-binding properties of diaminopropyl D-glucopyranoside and diaminopropyl D-mannopyranoside compounds in aqueous solution (2000) (8)
Structural studies of organoboron compounds. XXV. Synthesis and structure of (maltolato)diphenylboron (1987) (8)
Complexes of phosphine-phenolate ligands with the [Re=O]3+ and [Re(HNNC5H4N)(NNC5H4N)] 2+ cores (2001) (7)
Di- and Trivalent Metal-Ion Solution Studies with the Phosphinate-Containing Heterocycle DEDA-(PO). (2017) (7)
Werner Coordination Chemistry and Neurodegeneration (2013) (7)
RHENIUM COMPLEXES OF P,P,P',P'-TETRAKIS-(O-HYDROXYPHENYL)DIPHOSPHINOETHANE (1996) (7)
La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatments for bone resorption disorders. (2017) (7)
Phosphonate Chelators for Medicinal Metal Ions. (2021) (6)
Preparation of 2- and 4-substituted 3-hydroxy-5-methylfurans and the aluminum and gallium complexes of 3-hydroxy-5-methyl-2-(N-methylformamido)furan (1994) (6)
Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous system. (1994) (6)
Novel "bi-modal" H2dedpa derivatives for radio- and fluorescence imaging. (2016) (6)
Active oxygen species formation in synaptosomes exposed to an aluminum chelator. (1998) (5)
One-pot synthesis of N-substituted-3-hydroxy-4-pyridinone chelate complexes of aluminum, gallium, and indium (1989) (5)
Proton- and lanthanide-coordinating properties of the tetraaza macrocycle (EDDA-KA)2 in aqueous solution (2001) (5)
Glypican-3–Targeted 227Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma (2021) (5)
Lanthanide(III) and group 13 metal ion complexes of tripodal amino phosphinate ligands. (2006) (4)
mer-Tris[2-(5-bromo-2-hydroxyphenyl)-2-oxazolinato]aluminium(III) methanol solvate (1994) (4)
Aluminum and Gallium Compounds of 3-Hydroxy-4-pyridinones: Synthesis, Characterization, and Crystallography of Biologically Active Complexes with Unusual Hydrogen Bonding. (1988) (4)
Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents. (2020) (4)
[nat/89Zr][Zr(pypa)]: Thermodynamically Stable and Kinetically Inert Binary Nonadentate Complex for Radiopharmaceutical Applications. (2021) (4)
Structural studies of organoboron compounds. XXVII. (3-Hydroxy-2-methyl-4-pyridinonato)diphenylboron and (3-hydroxy-1,2-dimethyl-4-pyridinonato)diphenylboron (1988) (4)
Synthesis and characterization of lipophilic cationic Ga(III) complexes based on the H2CHXdedpa and H2dedpa ligands and their 67/68Ga radiolabeling studies (2016) (4)
One and Two Dimensional Pulsed Electron Paramagnetic Resonance Studies of in vivo Vanadyl Coordination in Rat Kidney (2003) (4)
Vanadium compounds as possible insulin modifiers (1999) (3)
[ReO(N2O2)X] complexes: "4 + 1"? (2001) (3)
Getting a lead on Pb2+-amide chelators for 203/212Pb radiopharmaceuticals. (2021) (3)
Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105. (2020) (3)
Structural studies of organoboron compounds. XLI. (3-Hydroxy-2-methyl-1-(p-tolyl)-4-pyridinonato)diphenylboron (1990) (3)
H4HBEDpa: Octadentate Chelate after A. E. Martell. (2021) (3)
H2pyhox - Octadentate Bis(pyridyloxine). (2021) (3)
Inorganic radiopharmaceutical chemistry of oxine. (2021) (3)
Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents. (2017) (3)
Main group (IIIA or 13) complexes of benzohydroxamic acid and the crystal structure of tris(benzohydroxamato)indium(III) (1988) (3)
High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [111In]In3+ and [89Zr]Zr4. (2021) (3)
Complexation of Ni2+ and Cu2+ by tripodal amine phenol ligands in aqueous solution† (1998) (3)
Design and Synthesis of Multidentate 2‐(2′‐Hydroxyphenyl)‐2‐ thiazolines for Biomedical Application. (1992) (3)
The Exoclathrate Al(C7H8NO2)3·12 H2O. A Facial Geometry Imposed by Extensive Hydrogen Bonding with the Ice I Structure. (1987) (2)
H2ampa─Versatile Chelator for [203Pb]Pb2+, [213Bi]Bi3+, and [225Ac]Ac3. (2022) (2)
Neutral Water-Soluble Post-Transition-Metal Chelate Complexes of Medical Interest: Aluminum and Gallium Tris(3-hydroxy-4-pyronates). (1987) (2)
Matching Chelators to Radiometals for Radiopharmaceuticals (2014) (2)
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons. (2021) (2)
Acyclic chelating ligands for PET imaging of tumor hypoxia with Ga-68 (2014) (2)
Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET. (2022) (2)
H4picoopa─Robust Chelate for 225Ac/111In Theranostics. (2022) (2)
Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis (2021) (2)
Metal ion size profoundly affects H3glyox chelate chemistry (2021) (2)
Polydentate Ligand Chemistry of Group 13 Metals: Effects of the Size and Donor Selectivity of Metal Ions on the Structures and Properties of Aluminum, Gallium, and Indium Complexes with Potentially Heptadentate (N4O3) Amine Phenol Ligands. (1993) (1)
H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics. (2022) (1)
Crystal structure of (2-hydroxy-5-methylphenyl)diphenylphosphineoxide, (C6H5)2P(O)(CH3C6H3OH) (2000) (1)
Neutral Water-Soluble Indium Complexes of 3-Hydroxy-4-pyrones and 3-Hydroxy-4-pyridinones. (1989) (1)
tBu4octapa-alkyl-NHS for metalloradiopeptide preparation. (2020) (1)
Selectivity among, and aggregation of, lanthanide ions (1997) (1)
(Acetonitrile)[N,N‐bis(3‐aminopropyl)‐1,3‐propanediamine‐N,N',N'',N''']copper(II) Diperchlorate (1996) (1)
phospa-Trastuzumab : Bifunctional Methylenephosphonate-based Chelator with 89 Zr , 111 In and 177 (2014) (1)
New Bifunctional Chelators for 225Ac and 227Th Radioimmunotherapy (2019) (1)
H4octapa-trastuzumab: An acyclic chelator-immunoconjugate with superior properties to DOTA for In-111/Lu-177 imaging and therapy (2013) (1)
Synthesis and characterization of a pentadentate Schiff base N[sub 3]O[sub 2] ligand and its neutral technetium(V) complex. X-ray structure of (N,N[prime]-3-azapentane-1,5-diylbis(3-(1-iminoethyl)-6-methyl-2H-pyran-2,4(3H)-dionato)(3-)-O,O[prime],N,N[prime],N[double prime])oxotechnetium(V) (1991) (1)
Toward 68Ga and 64Cu Positron Emission Tomography Probes: Is H2dedpa-N,N'-pram the Missing Link for dedpa Conjugation? (2023) (1)
Rapid Thermodynamically Stable Complex Formation of [nat/111In]In3+, [nat/90Y]Y3+, and [nat/177Lu]Lu3+ with H6dappa. (2020) (1)
Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). (1997) (1)
Insulin-mimetic vanadium complexes (1997) (1)
New bifunctional chelators for diagnostic and therapeutic radioisotopes (2019) (1)
Essential Metal Related Metabolic Disorders (2011) (1)
Metal Complexes of Maltol and Close Analogues in Medicinal Inorganic Chemistry (2006) (1)
[213Bi]Bi3+/[111In]In3+-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation. (2022) (1)
Study of the kinetics of complex formation and in vivo stability of novel radiometal-chelate conjugates for applications in nuclear medicine (2017) (0)
Alan Davison, FRS. (2016) (0)
Aluminum and Gallium Complexes of 1-Ethyl-3-hydroxy-2-methyl-4-pyridinone: A New Exoclathrate Matrix. (1989) (0)
H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [Ga]Ga (2020) (0)
Solution studies of the insulin-mimetic compound BMOV (1995) (0)
Bis(amido)bis(oxinate)diamine Ligands for theranostic radiometals. (2022) (0)
Vanadium compounds as insulin mimetic agents in the treatment of diabetes (1993) (0)
Radiolabeling and proof-of-principle in vivo studies using actinium-225 produced at TRIUMF’s isotope separation on-line facility (2019) (0)
Structure of (η‐cyclopentadienyl){(3R*,3aR*)‐5‐5a‐9a‐9b‐η‐3‐methoxy‐5‐trimethylsilyl‐2,3,3a,4,6,7,8,9‐octahydro‐1H‐benz[e]indene}cobalt, [Co(C5H5)(C17H28OSi)] (1985) (0)
Gallium-67 complexes for myocardial imaging. (1991) (0)
Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications (2021) (0)
Triaza-18-crown-6 macrocyclic chelators for the [203:212Pb]Pb2+ theranostic pair (2022) (0)
Design of Targeting Ligands in Medicinal Inorganic Chemistry (2006) (0)
Design , Synthesis , and Imaging of Small Amphiphilic Rhenium and 99 mTechnetium Tricarbonyl Complexes (2009) (0)
Retraction of "Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2". (2017) (0)
[N,N'-Bis(2-pyridylmethyl)ethylenediaminediacetato]cobalt(III) Perchlorate Monohydrate (1998) (0)
trans‐Tetrachlorobis(triphenylphosphine‐P)rhenium(IV)–mer‐trans‐Trichlorooxobis(triphenylphosphine‐P)rhenium(V) (0.86/0.14) (1996) (0)
Equilibrium and Structural Studies of Silicon(IV) and Aluminum(III) in Aqueous Solution. Part 18. Complexation of Aluminum with N-Substituted 3-Hydroxy-4-pyridinones. (1989) (0)
Kinetic studies of Al(III) and Ga(III) uptake by transferrin. (1991) (0)
H4octapa vs H4C3octapa: The difference of a single carbon atom (2014) (0)
Monocationic Ga and in complexes with modified amine pheols which possess a 3-dimensional N-2N2O-2 donor atom cavity (1995) (0)
Synthesis and solution studies of the complexes of trivalent lanthanides with the tetraazamacrocycle TETA-(PO)(2). (2002) (0)
Production of emerging theranostic radionuclides at TRIUMF (2022) (0)
Aluminum bioinorganic chemistry (1989) (0)
Structural Studies of Organoboron Compounds. Part 41. (3-Hydroxy-2- methyl-1-(p-tolyl)-4-pyridinonato)diphenylboron. (1991) (0)
Dalton transactions: providing the best services. (2008) (0)
TRIHOPO: 1,2-HOPO-based macrocyclic chelator for 225Ac, 227Th, and 89Zr (2022) (0)
Evaluation of [227Th]thorium chelation of hydroxypyridinone- and picolinic acid-containing ligands to simulate 226Th chelation (2019) (0)
Abstract 928: Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft model of hepatocellular carcinoma (2021) (0)
Dalton Transactions 40th Anniversary (2011) (0)
2008: a record year for Dalton Transactions! (2009) (0)
Acyclic chelators for PET imaging of hypoxia with 68Ga (2013) (0)
Announcment: 31st International Conference on Coordination Chemistry (1995) (0)
Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine (2022) (0)
Stan Kirschner―An appreciation (2009) (0)
Acyclic chelators as potential PET imaging agents of hypoxia with 68Ga (2014) (0)
1-Carboxymethyl-3-hydroxy-2-methyl-4(1H)-pyridinone (monoclinic form 2) (1994) (0)
General Method for the Synthesis of Trishydroxamic Acids. (1992) (0)
Metallodrugs for therapy and imaging : investigation of their mechanism of action (2018) (0)
Design of New Oxovanadium (IV) Complexes for Treatment of Diabetes. Biovailability, Speciation, and Tissue Targeting Considerations (2002) (0)
Proposal to the ISOLDE and Neutron Time-of-Flight Committee Study of the kinetics of complex formation and in vivo stability of novel radiometal-chelate conjugates for applications in nuclear medicine . 11 January 2017 (2017) (0)
Development of small amphiphilic Rhenium and Tc-99m tricarbonyl complexes (2009) (0)
A highly stable functionalizable chelator for 67Ga/68Ga (2010) (0)
Lanthanoid Complexes of Potentially Heptadentate Ligands Including the Structure of (Tris(3-aza-4-methylhept-4-ene-6-on-1-yl)amine)tris(nitrato)gadolinium(III). (1989) (0)

This paper list is powered by the following services:

Other Resources About Chris Orvig

www.chem.ubc.ca

What Schools Are Affiliated With Chris Orvig?

Chris Orvig is affiliated with the following schools:

University of Queensland
University of Mainz
University of British Columbia
Massachusetts Institute of Technology

Chris Orvig's Academic­Influence.com Rankings